Financial Performance - Entegris's net sales for 1Q25 were $773.2 million, a 0.3% increase compared to $771.0 million in 1Q24, but a 9.0% decrease compared to $849.8 million in 4Q24 [5] - The company's GAAP net income for 1Q25 was $62.9 million, a 38.9% increase compared to $45.3 million in 1Q24, but a 38.5% decrease compared to $102.3 million in 4Q24 [5] - Diluted earnings per common share were $0.41 in 1Q25, up 36.7% from $0.30 in 1Q24, but down 38.8% from $0.67 in 4Q24 [5] - Adjusted EBITDA for 1Q25 was $220.7 million, representing 28.5% of net sales [6] Segment Performance - Materials Solutions (MS) segment net sales were $341.4 million in 1Q25, a 2.5% decrease compared to $350.0 million in 1Q24, but excluding divestiture, adjusted net sales increased by 8.0% to $341.4 million from $316.1 million [9] - Advanced Purity Solutions (APS) segment net sales were $433.9 million in 1Q25, a 2.5% increase compared to $423.3 million in 1Q24, but an 11.7% decrease compared to $491.2 million in 4Q24 [12] Balance Sheet and Cash Flow - Cash and cash equivalents at the end of 1Q25 were $340.9 million [15] - Long-term debt was $3.9845 billion [15] - Cash provided by operating activities in 1Q25 was $140.4 million [16] Outlook - The company's net sales guidance for 2Q25 is $735 million to $775 million [17, 18] - Non-GAAP net income is projected to be between $91 million and $102 million [18]

[Entegris First Quarter 2025 Earnings Release](index=1&type=section&id=Entegris%20First%20Quarter%202025%20Earnings%20Release) [First Quarter 2025 Financial Highlights](index=1&type=section&id=First%20Quarter%202025%20Financial%20Highlights) The company reported 5% year-over-year adjusted revenue growth, managed tariff impacts, and focused on improving profitability and cash flow - CEO Bertrand Loy highlighted that Q1 revenue grew **5% year-over-year** (excluding divestitures) and that gross margin, EBITDA margin, and non-GAAP EPS were within guidance[2](index=2&type=chunk) - Despite increased uncertainty from new tariffs, the company is focused on leveraging its global footprint to mitigate impacts, improving free cash flow, and paying down debt[2](index=2&type=chunk) - **Net Sales (as reported):** $773 million, an increase of 0.3% from the prior year[4](index=4&type=chunk) - **Adjusted Net Sales (excluding divestiture):** Increased 5% from the prior year[4](index=4&type=chunk) - **GAAP Diluted EPS:** $0.41[4](index=4&type=chunk) - **Non-GAAP Diluted EPS:** $0.67[4](index=4&type=chunk) Q1 2025 Financial Results Summary (GAAP vs. Non-GAAP) | Metric | Mar 29, 2025 (Q1'25) | Mar 30, 2024 (Q1'24) | Dec 31, 2024 (Q4'24) | | :--- | :--- | :--- | :--- | | **GAAP Results** | | | | | Net Sales | $773.2 M | $771.0 M | $849.8 M | | Gross Margin % | 46.1% | 45.6% | 45.6% | | Operating Margin % | 15.8% | 15.3% | 17.7% | | Net Income | $62.9 M | $45.3 M | $102.3 M | | Diluted EPS | $0.41 | $0.30 | $0.67 | | **Non-GAAP Results** | | | | | Adjusted Gross Margin % | 46.1% | 45.6% | 45.6% | | Adjusted Operating Margin % | 22.1% | 23.1% | 23.5% | | Adjusted EBITDA % | 28.5% | 29.0% | 29.2% | | Diluted Non-GAAP EPS | $0.67 | $0.68 | $0.84 | [Business Outlook](index=2&type=section&id=Business%20Outlook) The company projects Q2 2025 sales between $735 million and $775 million, with non-GAAP diluted EPS expected to be $0.60 to $0.67 Second Quarter 2025 Guidance | Metric | Q2 2025 Outlook | | :--- | :--- | | Sales | $735 M - $775 M | | GAAP Net Income | $51 M - $62 M | | GAAP Diluted EPS | $0.34 - $0.41 | | Non-GAAP Net Income | $91 M - $102 M | | Non-GAAP Diluted EPS | $0.60 - $0.67 | | Adjusted EBITDA | ~27.5% of sales | [Segment Performance](index=2&type=section&id=Segment%20Performance) The Advanced Purity Solutions segment led in revenue, while the Materials Solutions segment showed year-over-year profit growth - **Materials Solutions (MS):** Provides materials-based solutions like chemical vapor deposition materials, CMP slurries and pads, and specialty gases to improve device performance and yield[6](index=6&type=chunk)[7](index=7&type=chunk) - **Advanced Purity Solutions (APS):** Offers filtration, purification, and contamination-control solutions to ensure the purity of critical liquids and gases in semiconductor manufacturing[6](index=6&type=chunk)[7](index=7&type=chunk) Segment Results (in millions) | Metric | Mar 29, 2025 (Q1'25) | Mar 30, 2024 (Q1'24) | Dec 31, 2024 (Q4'24) | | :--- | :--- | :--- | :--- | | **Net Sales** | | | | | Materials Solutions | $341.4 | $350.0 | $361.1 | | Advanced Purity Solutions | $433.9 | $423.3 | $491.2 | | **Segment Profit** | | | | | Materials Solutions | $75.0 | $67.1 | $77.1 | | Advanced Purity Solutions | $108.1 | $111.2 | $134.9 | [Consolidated Financial Statements (Unaudited)](index=5&type=section&id=Consolidated%20Financial%20Statements%20(Unaudited)) [Condensed Consolidated Statements of Operations](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) Net sales increased slightly year-over-year to $773.2 million, driving significant growth in net income to $62.9 million Q1 2025 Statement of Operations (in millions, except per share data) | Line Item | Mar 29, 2025 | Mar 30, 2024 | Dec 31, 2024 | | :--- | :--- | :--- | :--- | | Net sales | $773.2 | $771.0 | $849.8 | | Gross profit | $356.5 | $351.8 | $387.3 | | Operating income | $122.3 | $117.6 | $150.0 | | Income before income tax expense | $71.4 | $48.9 | $112.5 | | Net income | $62.9 | $45.3 | $102.3 | | Diluted earnings per common share | $0.41 | $0.30 | $0.67 | [Condensed Consolidated Balance Sheets](index=6&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Total assets reached $8.43 billion, supported by $3.75 billion in shareholders' equity and balanced by $3.98 billion in long-term debt Balance Sheet Highlights (in millions) | Account | Mar 29, 2025 | Dec 31, 2024 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $340.9 | $329.2 | | Total current assets | $1,670.2 | $1,616.3 | | Goodwill | $3,943.9 | $3,943.6 | | Total assets | $8,431.4 | $8,394.6 | | **Liabilities and Equity** | | | | Total current liabilities | $512.6 | $525.2 | | Long-term debt | $3,984.5 | $3,981.1 | | Shareholders' equity | $3,749.4 | $3,691.5 | | Total liabilities and equity | $8,431.4 | $8,394.6 | [Condensed Consolidated Statements of Cash Flows](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) The company generated $140.4 million in operating cash flow, funding capital expenditures and ending the quarter with $340.9 million in cash Cash Flow Summary for Three Months Ended (in millions) | Activity | Mar 29, 2025 | Mar 30, 2024 | | :--- | :--- | :--- | | Net cash provided by operating activities | $140.4 | $147.2 | | Net cash (used in) provided by investing activities | $(108.3) | $181.0 | | Net cash used in financing activities | $(22.4) | $(439.9) | | Increase (decrease) in cash and cash equivalents | $11.7 | $(116.2) | | Cash and cash equivalents at end of period | $340.9 | $340.7 | [Reconciliations of GAAP to Non-GAAP Measures](index=9&type=section&id=Reconciliations%20of%20GAAP%20to%20Non-GAAP%20Measures) [Reconciliation of GAAP Gross Profit to Adjusted Gross Profit](index=9&type=section&id=Reconciliation%20of%20GAAP%20Gross%20Profit%20to%20Adjusted%20Gross%20Profit) Q1 2025 GAAP gross profit was adjusted for minor restructuring costs, resulting in an adjusted gross profit of $356.7 million Gross Profit Reconciliation (in millions) | Line Item | Mar 29, 2025 | Mar 30, 2024 | Dec 31, 2024 | | :--- | :--- | :--- | :--- | | Gross profit-GAAP | $356.5 | $351.8 | $387.3 | | Restructuring costs | 0.2 | — | 0.4 | | Adjusted gross profit | $356.7 | $351.8 | $387.7 | [Reconciliation of GAAP Segment Profit to Adjusted Operating Income](index=10&type=section&id=Reconciliation%20of%20GAAP%20Segment%20Profit%20to%20Adjusted%20Operating%20Income) Adjustments to segment profits for restructuring costs yielded a total adjusted operating income of $170.8 million for Q1 2025 Adjusted Operating Income Reconciliation (in millions) | Line Item | Mar 29, 2025 | Mar 30, 2024 | Dec 31, 2024 | | :--- | :--- | :--- | :--- | | MS adjusted segment profit | $75.1 | $75.3 | $78.2 | | APS adjusted segment profit | $110.4 | $111.2 | $137.1 | | Total adjusted segment profit | $185.5 | $186.5 | $215.3 | | Less: adjusted unallocated G&A | (14.7) | (8.4) | (15.2) | | **Total adjusted operating income** | **$170.8** | **$178.1** | **$200.1** | [Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA](index=11&type=section&id=Reconciliation%20of%20GAAP%20Net%20Income%20to%20Adjusted%20Operating%20Income%20and%20Adjusted%20EBITDA) Adjusted EBITDA for Q1 2025 was $220.7 million, reconciled from GAAP net income by adding back taxes, interest, and other non-cash charges Adjusted EBITDA Reconciliation (in millions) | Line Item | Mar 29, 2025 | Mar 30, 2024 | Dec 31, 2024 | | :--- | :--- | :--- | :--- | | Net income | $62.9 | $45.3 | $102.3 | | GAAP - Operating income | 122.3 | 117.6 | 150.0 | | Amortization of intangible assets | 46.1 | 50.2 | 46.2 | | Adjusted operating income | 170.8 | 178.1 | 200.1 | | Depreciation | 49.9 | 45.3 | 48.3 | | **Adjusted EBITDA** | **$220.7** | **$223.4** | **$248.4** | [Reconciliation of GAAP Net Income and Diluted Earnings per Common Share to Non-GAAP Net Income and Diluted Non-GAAP Earnings per Common Share](index=12&type=section&id=Reconciliation%20of%20GAAP%20Net%20Income%20and%20Diluted%20Earnings%20per%20Common%20Share%20to%20Non-GAAP%20Net%20Income%20and%20Diluted%20Non-GAAP%20Earnings%20per%20Common%20Share) Non-GAAP net income reached $101.5 million ($0.67 per share) after adjusting for amortization of intangibles and restructuring costs Non-GAAP Net Income and EPS Reconciliation (in millions, except per share data) | Line Item | Mar 29, 2025 | Mar 30, 2024 | Dec 31, 2024 | | :--- | :--- | :--- | :--- | | GAAP net income | $62.9 | $45.3 | $102.3 | | Amortization of intangible assets | 46.1 | 50.2 | 46.2 | | Restructuring costs | 2.4 | — | 3.9 | | Tax effect of adjustments | (9.9) | (13.6) | (6.9) | | **Non-GAAP net income** | **$101.5** | **$103.8** | **$127.5** | | GAAP Diluted EPS | $0.41 | $0.30 | $0.67 | | **Diluted non-GAAP EPS** | **$0.67** | **$0.68** | **$0.84** | [Reconciliation of Reported Net Sales to Adjusted Net Sales (excluding divestiture) Non-GAAP](index=13&type=section&id=Reconciliation%20of%20Reported%20Net%20Sales%20to%20Adjusted%20Net%20Sales%20(excluding%20divestiture)%20Non-GAAP) Q1 2024 net sales were adjusted to $737.1 million to exclude a divested business, providing a basis for like-for-like comparison Adjusted Net Sales Reconciliation (in millions) | Line Item | Mar 29, 2025 | Mar 30, 2024 | Dec 31, 2024 | | :--- | :--- | :--- | :--- | | Net sales | $773.2 | $771.0 | $849.8 | | Less: divestiture | — | (33.9) | — | | Adjusted net sales (Non-GAAP) | $773.2 | $737.1 | $849.8 | [Reconciliation of GAAP Outlook to Non-GAAP Outlook](index=14&type=section&id=Reconciliation%20of%20GAAP%20Outlook%20to%20Non-GAAP%20Outlook) The Q2 2025 GAAP outlook is adjusted for expected amortization of intangibles to provide a non-GAAP forecast Q2 2025 Outlook Reconciliation | Metric | GAAP Outlook | Adjustments | Non-GAAP Outlook | | :--- | :--- | :--- | :--- | | Net Income (in millions) | $51 - $62 | $40 | $91 - $102 | | Diluted EPS | $0.34 - $0.41 | $0.26 | $0.60 - $0.67 | [Appendix](index=2&type=section&id=Appendix) [Non-GAAP Information](index=2&type=section&id=Non-GAAP%20Information) The company utilizes non-GAAP measures to offer investors a clearer view of ongoing business performance and future outlook - The Company provides supplemental non-GAAP financial measures to better understand its business, believing they offer investors additional meaningful information for assessing ongoing results[11](index=11&type=chunk) - Management uses these measures to evaluate segment performance and believes they help indicate baseline performance before certain charges not indicative of the business's future outlook[11](index=11&type=chunk) [Cautionary Note on Forward-Looking Statements](index=4&type=section&id=Cautionary%20Note%20on%20Forward-Looking%20Statements) This release contains forward-looking statements subject to significant risks and uncertainties that could impact future performance - The news release contains forward-looking statements based on current management expectations, which are not guarantees of future performance[13](index=13&type=chunk) - These statements involve substantial risks and uncertainties that could cause actual results to differ materially, including fluctuations in semiconductor demand, global economic uncertainty, and tariffs[13](index=13&type=chunk)

Core Points - Entourage Health Corp. has completed a plan of arrangement where 1001095275 Ontario Inc., a related party of LiUNA Pension Fund, acquired all issued and outstanding common shares of the Company for cash consideration of C$0.005 per share, effective March 31, 2025 [1][2] - The arrangement also included the same cash consideration for holders of certain vested convertible securities and involved debt settlement agreements for C$1,013,050 in unsecured debentures, settled for C$250,000 [2] - The arrangement was approved by shareholders on March 21, 2025, and by the Superior Court of Justice on March 26, 2025 [3] Company Overview - Entourage Health Corp. is a publicly traded parent company of Entourage Brands Corp., which produces and distributes cannabis products for medical and adult-use markets [8] - The Company operates a fully licensed processing facility in Aylmer, Ontario, and has a multi-channel distribution strategy, including partnerships with LiUNA and various provincial distribution agencies [8] - Entourage's product portfolio includes brands such as Starseed Medicinal, Color Cannabis, and Saturday Cannabis, and it is the exclusive Canadian producer of the wellness brand Mary's Medicinals [8] Post-Arrangement Plans - Following the completion of the arrangement, Entourage intends to delist its common shares from the TSX Venture Exchange, Frankfurt Stock Exchange, and OTC Markets, and will apply to cease being a reporting issuer [4] - Shareholders are required to surrender their share certificates and complete a Letter of Transmittal to receive their cash consideration [5][6]

Core Points - Entourage Health Corp. has amended its credit facilities, increasing the Subordinated Facility by approximately $3,000,000 and extending the maturity date to December 31, 2025 [2][3] - The lender for both facilities is 2437653 Ontario Inc., a related party of the LiUNA Pension Fund of Central and Eastern Canada [1][4] - The company has received a forbearance letter from LPF, waiving breaches under the facilities until specific conditions are met [3] Company Overview - Entourage Health Corp. is a Canadian producer and distributor of cannabis products, operating a fully licensed 26,000 sq. ft. processing facility in Aylmer, Ontario [6] - The company has a multi-channel distribution strategy, including partnerships with the largest construction union in Canada and exclusive agreements with wellness brands [6]

Core Points - Entourage Health Corp. has received shareholder approval for a plan of arrangement involving the acquisition of all common shares by 1001095275 Ontario Inc. for cash consideration of $0.005 per share [1][2] - The special resolution for the arrangement was approved by 95.647% of votes cast by shareholders present or represented by proxy, and 90.477% excluding the Purchaser and Guarantor [3] - The arrangement is expected to be effective around March 31, 2025, pending a final order from the Ontario Superior Court of Justice and other customary closing conditions [4] Company Overview - Entourage Health Corp. is a publicly traded parent company of Entourage Brands Corp., which produces and distributes cannabis products for medical and adult-use markets [7] - The company operates a fully licensed processing facility in Aylmer, Ontario, covering 26,000 square feet [7] - Entourage has a multi-channel distribution strategy, including partnerships with LiUNA, the largest construction union in Canada, and offers a range of cannabis brands [7] Additional Information - Registered shareholders must submit a Letter of Transmittal and share certificates to TSX Trust Company to receive cash consideration after the arrangement closes [5] - More details about the arrangement can be found in the management information circular dated February 10, 2025, available on SEDAR+ [6] - The LiUNA Pension Fund of Central and Eastern Canada, involved in the arrangement, is one of the fastest-growing multi-employer pension funds in Canada with over $12 billion in assets [9]

Core Points - Entegris Inc. will replace Arcadium Lithium plc in the S&P MidCap 400 effective March 6, 2025 [1] - Rio Tinto plc is acquiring Arcadium Lithium, with the deal expected to be completed soon [1] Summary by Category Index Changes - Effective March 6, 2025, Entegris will be added to the S&P MidCap 400 under the ticker ENTG in the Information Technology sector [1] - Arcadium Lithium will be deleted from the S&P MidCap 400 under the ticker ALTM in the Materials sector [1]

Financial Performance - For the year ended December 31, 2024, net sales were $3,241.2 million, a decrease of $282.7 million, or 8%, from 2023[218] - The decrease in net sales was primarily due to the absence of $434.2 million in sales associated with divested businesses and a reduction of $23.4 million from unfavorable foreign currency translation effects[219] - Gross profit for 2024 was $1,486.7 million, representing 45.9% of net sales, compared to $1,497.6 million, or 42.5% of net sales in 2023[218] - Operating income increased to $533.9 million, or 16.5% of net sales, compared to $499.2 million, or 14.2% of net sales in 2023[218] - The company reported net income of $292.8 million, or 9.0% of net sales, compared to $180.7 million, or 5.1% in 2023[218] - Net income rose to $292.8 million, or $1.93 per diluted share, in 2024, compared to $180.7 million, or $1.20 per diluted share, in 2023[234] - Adjusted Operating Income decreased by 3.5% to $742.9 million in 2024, while Non-GAAP EPS increased by 13.6% to $3.00[237] - Non-GAAP net income for 2024 was $455,988, with diluted non-GAAP earnings per share at $3.00, compared to $398,918 and $2.64 in 2023[292] Expenses and Costs - Engineering, research and development expenses rose to $316.1 million, or 9.8% of net sales, up from $277.3 million, or 7.9% in 2023[218] - SG&A expenses decreased by $129.6 million, or 22%, to $446.6 million in 2024 from $576.2 million in 2023[222] - Interest expense decreased to $215.2 million, or 6.6% of net sales, from $312.4 million, or 8.9% in 2023[218] - The company recorded a goodwill impairment of $115,217 in 2023, which was not present in 2024[292] - Interest expense decreased from $312,378 in 2023 to $215,217 in 2024, reflecting improved financial management[291] Sales and Market Performance - North America sales decreased by 25% to 21% of total sales in 2024, while Taiwan sales increased by 12% to 20%[220] - Materials Solutions net sales decreased by 17% to $1,400.1 million in 2024, primarily due to the absence of $434.2 million in sales from divested businesses[242] - Advanced Purity Solutions reported flat net sales of approximately $1,850.2 million in 2024, with a segment profit decrease of 7% to $496.1 million[246] Cash Flow and Debt Management - Total debt decreased to $3,981.1 million in 2024 from $4,577.1 million in 2023[251] - Cash and cash equivalents decreased to $329.2 million in 2024 from $456.9 million in 2023[251] - In 2024, the net cash provided by operating activities was $631.7 million, a decrease of $12.8 million compared to $644.5 million in 2023[254] - Cash used in investing activities in 2024 was $67.1 million, a significant decrease from $553.1 million provided in 2023, primarily due to less proceeds from divestitures of $564.2 million[258] - Cash used in financing activities was $689.0 million in 2024, down from $1,297.5 million in 2023, mainly due to decreased net debt activity of $635.9 million[261] - Total debt (par value) decreased to $4.045 billion as of December 31, 2024, from $4.669 billion in 2023[263] - The company repaid $623.8 million net of borrowings under the term loans B during the fiscal year 2024[264] - The company had cash requirements totaling $5.414 billion as of December 31, 2024, with $395.6 million due within one year[269] Future Outlook and Investments - The company expects capital expenditure spending to be approximately $325.0 million in 2025, including investments in a new manufacturing facility in Colorado Springs, Colorado[271] - The company entered into a definitive agreement with the U.S. Department of Commerce for up to $77.0 million in funding under the CHIPS and Science Act to support a new facility in Colorado Springs[212] Currency and Interest Rate Impact - A 100-basis point change in interest rates could impact annual net income by approximately $2.5 million in 2024 and $3.4 million in 2023[293] - Approximately 16.7% of sales in 2024 were denominated in foreign currencies, which could lead to a revenue decrease of about $53.2 million if those currencies depreciate by 10% against the U.S. dollar[294] Other Financial Metrics - Adjusted EBITDA for 2024 was $931,074, accounting for 28.7% of net sales, compared to $942,355 and 26.7% in 2023[291] - Goodwill impairment was recorded at $115.2 million in 2023, with no impairment recorded in 2024[218] - The company utilized non-GAAP financial measures, including Adjusted EBITDA and Non-GAAP EPS, to provide additional insights into its performance[277]

2 This presentation contains forward looking statements. The words "believe," "expect," "anticipate," "intend," "estimate," "forecast," "project," "should," "may," "will," "would" or the negative thereof and similar expressions are intended to identify such forward looking statements. These forward looking statements may include statements about the ongoing impacts of the COVID-19 pandemic and the conflict in Ukraine on the Company's operations and markets, including supply chain issues and inflationary pre ...

Financial Data and Key Metrics Changes - In Q4 2024, revenue excluding divestitures grew 11% year on year, exceeding guidance [7] - Full-year revenue grew more than 5% excluding divestitures and currency impact, yielding an estimated market outperformance of 4% [10] - Gross margin for Q4 was 45.6%, and EBITDA margin expanded more than 100 basis points year on year to reach 28.7% [13][22] Business Line Data and Key Metrics Changes - Material Solutions division sales in Q4 were $361 million, up 14% year on year, driven by CMP consumables, advanced deposition materials, and etching chemistries [24] - Advanced Purity Solutions division sales in Q4 were $491 million, up 9% year on year, with growth in fluid handling, wafer handling, and gas purification [26] Market Data and Key Metrics Changes - Semiconductor customers with significant exposure to advanced logic and AI performed well, while the rest of the industry remained weak throughout 2024 [9] - The company expects the semiconductor market to grow between 1% and 3% in 2025, with an anticipated outperformance of four to five points [19] Company Strategy and Development Direction - The company is focused on delivering strong market outperformance, improving free cash flow, and paying down debt while funding critical investments for long-term competitiveness [36] - The company is optimistic about the long-term growth outlook of the semiconductor industry, driven by complex device architectures and miniaturization [37] Management's Comments on Operating Environment and Future Outlook - Management noted limited visibility outside of advanced logic and AI-driven applications as they enter 2025 [18] - The company anticipates a significant revenue loss of $30 million to $40 million in 2025 due to new restrictions on sales to China [20][101] Other Important Information - The company paid down almost $625 million of debt in 2024, with a focus on continuing debt reduction in 2025 [15] - The new facility in Kaohsiung, Taiwan is progressing well, with product qualifications expected to be completed by the end of the year [17] Q&A Session Summary Question: Market outlook and outperformance - Management indicated that wafer starts are expected to be up in the low single digits, with limited visibility in mainstream and traditional memory [43][44] Question: Working capital optimization - Management emphasized the importance of improving free cash flow margins and optimizing working capital, particularly inventory [51][55] Question: March quarter guidance - Management noted that guidance for Q1 is in line with normal seasonal market decline, expecting a sequential decline in wafer starts [59] Question: Advanced packaging growth - Management highlighted that advanced packaging revenues are approaching $100 million and expect significant growth in 2025 [63][64] Question: Impact of China restrictions - Management confirmed that the new restrictions will impact both divisions, leading to an estimated annual revenue loss of $30 million to $40 million [101] Question: Supply constraints - Management stated that supplier issues discussed in previous quarters are largely resolved, with improvements expected in Q1 [108] Question: Tariff impacts - Management is monitoring the impact of tariffs but expects immaterial effects on raw material costs due to established local supply chains [111] Question: Silicon carbide growth - Management noted that silicon carbide revenue was flat year on year but remains a promising area for future growth [148]

Group 1 - Entegris reported quarterly earnings of $0.84 per share, exceeding the Zacks Consensus Estimate of $0.77 per share, and up from $0.65 per share a year ago, representing an earnings surprise of 9.09% [1] - The company achieved revenues of $849.84 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 3.36% and increasing from $812.29 million year-over-year [2] - Entegris has outperformed the S&P 500, gaining approximately 4.9% since the beginning of the year compared to the S&P 500's gain of 3.1% [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is $0.76 on revenues of $805.87 million, and for the current fiscal year, it is $3.63 on revenues of $3.54 billion [7] - The Electronics - Manufacturing Machinery industry, to which Entegris belongs, is currently ranked in the bottom 10% of over 250 Zacks industries, indicating potential challenges for stock performance [8] Group 3 - The estimate revisions trend for Entegris is currently unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, suggesting expected underperformance in the near future [6] - Cohu, another company in the same industry, is anticipated to report a quarterly loss of $0.11 per share, with a significant year-over-year decline in revenues expected [9]